These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9705906)

  • 1. An anti-HIV peptide construct derived from the cleavage region of the Env precursor acts on Env fusogenicity through the presence of a functional cleavage sequence.
    Barbouche R; Sabatier JM; Fenouillet E
    Virology; 1998 Aug; 247(2):137-43. PubMed ID: 9705906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.
    Bahbouhi B; Chazal N; Seidah NG; Chiva C; Kogan M; Albericio F; Giralt E; Bahraoui E
    Biochem J; 2002 Sep; 366(Pt 3):863-72. PubMed ID: 12071862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant HIV envelope expressed in an alpha-glucosidase I-deficient CHO cell line and its parental cell line in the presence of 1-deoxynojirimycin is functional.
    Fenouillet E; Papandréou MJ; Jones IM
    Virology; 1997 Apr; 231(1):89-95. PubMed ID: 9143306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain (gp41) of the human immunodeficiency virus type 1 envelope.
    Sabatier JM; Mabrouk K; Moulard M; Rochat H; Van Rietschoten J; Fenouillet E
    Virology; 1996 Sep; 223(2):406-8. PubMed ID: 8806580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-1 Env protein signal sequence retards its cleavage and down-regulates the glycoprotein folding.
    Li Y; Luo L; Thomas DY; Kang CY
    Virology; 2000 Jul; 272(2):417-28. PubMed ID: 10873786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles.
    Herrera C; Klasse PJ; Michael E; Kake S; Barnes K; Kibler CW; Campbell-Gardener L; Si Z; Sodroski J; Moore JP; Beddows S
    Virology; 2005 Jul; 338(1):154-72. PubMed ID: 15932765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
    Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
    Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
    Johnson JE; Rodgers W; Rose JK
    Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules.
    Ohgimoto S; Tabata N; Suga S; Nishio M; Ohta H; Tsurudome M; Komada H; Kawano M; Watanabe N; Ito Y
    J Immunol; 1995 Oct; 155(7):3585-92. PubMed ID: 7561057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion.
    Moulard M; Montagnier L; Bahraoui E
    FEBS Lett; 1994 Feb; 338(3):281-4. PubMed ID: 8307195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathological cleavage of human immunodeficiency virus gp160 protein in infected cells as a probable factor for infection becoming chronic].
    Veselovskaia TV; Rykova LA; Selimova LM; Zaĭdes VM
    Mol Biol (Mosk); 1993; 27(1):211-21. PubMed ID: 8483471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain.
    Wilk T; Pfeiffer T; Bukovsky A; Moldenhauer G; Bosch V
    Virology; 1996 Apr; 218(1):269-74. PubMed ID: 8615034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E; Hummer G; Bewley CA; Clore GM
    J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
    Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
    Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.